RETIRED: Teratogenicity Associated With Pre-Existing and Gestational Diabete
Tài liệu tham khảo
Health Canada, 2002
Wilson, 2007, Principles of human teratology: drug, chemical, and infectious exposure. SOGC Clinical Practice Guidelines, No. 199, November 2007, J Obstet Gynaecol Can, 29, 911, 10.1016/S1701-2163(16)32668-8
Woolf, 2003, Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care, Can Med Assoc J, 169, 207
American Diabetes Association, 2005, Diagnosis and classification of diabetes mellitus, Diabetes Care, 28, S37, 10.2337/diacare.28.suppl_1.S37
Zaw, 2002, Caudal regression syndrome in twin pregnancy with type II diabetes, J Perinatol, 2, 171, 10.1038/sj.jp.7210614
Lian, 2004, Enhanced inflammatory response in neural tubes of embryos derived from diabetic mice exposed to a teratogen, J Neuroscience Res, 75, 554, 10.1002/jnr.20006
Punareewattana, 2003, Reduced birth defects caused by maternal immune stimulation may involve increased expression of growth promoting genes and cytokine GM-CSF in the spleen of diabetic ICR mice, Int Immunopharmacol, 3, 1639, 10.1016/S1567-5769(03)00200-5
Meltzer, 2003
Aberg, 2001, Congenital malformations among infants whose mothers had gestational diabetes or pre-existing diabetes, Early Human Develop, 61, 85, 10.1016/S0378-3782(00)00125-0
Martinez-Frias, 1998, Epidemiological analysis of outcomes of pregnancy in gestational diabetic mothers, Am J Med Genetics, 78, 140, 10.1002/(SICI)1096-8628(19980630)78:2<140::AID-AJMG8>3.0.CO;2-S
Sheffield, 2002, Maternal diabetes and infant malformations, Obstet Gynecol, 100, 925
Sharpe, 2005, Maternal diabetes and congenital anomalies in South Australia 1986–2000: a population-based cohort study, Birth Defects Res, 73, 605, 10.1002/bdra.20172
Martinez-Frias, 2002, Epidemiological evidence that maternal diabetes does not appear to increase the risk for Down syndrome, Am J Med Genetics, 112, 335, 10.1002/ajmg.10706
Towner, 1995, Congenital malformations in pregnancies complicated by NIDDM. Increase risk from poor maternal metabolic control but not from exposure to sulfonylurea drugs, Diabetes Care, 18, 1446, 10.2337/diacare.18.11.1446
Casson, 1997, Outcomes of pregnancy in insulin dependent diabetic women: results of a five-year population cohort study, BMJ, 315, 275, 10.1136/bmj.315.7103.275
Evers, 2004, Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands, BMJ, 328, 915, 10.1136/bmj.38043.583160.EE
Jensen, 2004, Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study, Diabetes Care, 27, 2819, 10.2337/diacare.27.12.2819
Dunne, 2000, Fetal and maternal outcomes in Indo-Asian compared to Caucasian women with diabetes in pregnancy, Q J Med, 93, 813, 10.1093/qjmed/93.12.813
Kitzmiller, 1991, Preconception care of diabetes. Glycemic control prevents congenital anomalies, JAMA, 265, 731, 10.1001/jama.1991.03460060063025
Langer, 2000, Level of glycemia and perinatal outcome in pregestational diabetes, J Mat Fet Med, 9, 35, 10.1002/(SICI)1520-6661(200001/02)9:1<35::AID-MFM8>3.0.CO;2-6
American Diabetes Association, 2000, Gestational diabetes mellitus, Diabetes Care, 23, S77
Temple, 2002, Association between outcome of pregnancy in type 1 diabetes: population based study, BMJ, 325, 1275, 10.1136/bmj.325.7375.1275
The Diabetes Control Complications Trial Research Group, 1996, Pregnancy outcomes in the Diabetes Control and Complications trial, Am J Obstet Gynecol, 174, 1343, 10.1016/S0002-9378(96)70683-X
Schaefer-Graf, 2000, Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by Type 2 and gestational diabetes, Am J Obstet Gynecol, 182, 313, 10.1016/S0002-9378(00)70217-1
Hanson, 1990, Relationship between haemoglobin A1C in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden, Diabetologia, 33, 100, 10.1007/BF00401047
Farrell, 2002, Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes, Diabet Med, 19, 322, 10.1046/j.1464-5491.2002.00700.x
Naylor, 1996, Cesarean delivery in relation to birth weight and gestational glucose intolerance: pathophysiology or practice style? Toronto Tri-Hospital Gestational Diabetes Investigators, JAMA, 275, 1165, 10.1001/jama.1996.03530390031030
Kousseff, 1999, Gestational diabetes mellitus (Class A): a human teratogen?, Am J Med Gen, 83, 402, 10.1002/(SICI)1096-8628(19990423)83:5<402::AID-AJMG12>3.0.CO;2-F
Versiani, 2004, Caudal dysplasia sequence: severe phenotype presenting in offspring of patients with gestational and pregestational diabetes, Clin Dysmorphol, 13, 1, 10.1097/00019605-200401000-00001
American Diabetes Association, 2005, Gestational diabetes mellitus, Diabetes Care, 25, S82, 10.2337/diacare.25.2007.S82
Berger, 2002, Screening for gestational diabetes, J Obstet Gynaecol Can, 24, 894, 10.1016/S1701-2163(16)31047-7
Merlob, 2002, Oral antihyperglycemic agents during pregnancy and lactation: a review, Paediatr Drugs, 4, 755, 10.2165/00128072-200204110-00007
Mokdad, 2003, Prevalence of obesity, diabetes and obesity-related health risk factors, 2001, JAMA, 298, 76, 10.1001/jama.289.1.76
Dolci, 2005, Use of glargine insulin before and during pregnancy in a woman with type I diabetes and Addison’s disease, Diabetes Care, 28, 2084, 10.2337/diacare.28.8.2084-a
Di Cianni, 2005, Use of insulin glargine during the first weeks of pregnancy in five type I diabetic women, Diabetes Care, 28, 982, 10.2337/diacare.28.4.982
Woolderink, 2005, Use of insulin glargine during pregnancy in seven type I diabetic women, Diabetes Care, 28, 2594, 10.2337/diacare.28.10.2594
Watkins, 2003, Maternal obesity and risk of birth defects, Pediatr, 111, 1152, 10.1542/peds.111.S1.1152
Hofmann, 2002, Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (LANTUS) in rats and rabbits, Int J Toxicol, 21, 181, 10.1080/10915810290096315
Shaw, 1996, Risk of neural tube defect-affected pregnancies among obese women, JAMA, 275, 1093, 10.1001/jama.1996.03530380035028
Cedergren, 2003, Maternal obesity and infant heart defects, Obes Res, 11, 1065, 10.1038/oby.2003.146
Anderson, 2005, Maternal obesity, gestational diabetes, and central nervous system birth defects, Epidemiol, 16, 87, 10.1097/01.ede.0000147122.97061.bb
Moore, 2000, A prospective study of the risk of congenital defects associated with maternal obesity and diabetes mellitus, Epidemiol, 11, 689, 10.1097/00001648-200011000-00013
Martinez-Frias, 2005, Pre-gestational maternal body mass index predicts an increased risk of congenital malformations in infants of mothers with gestational diabetes, Diabet Med, 22, 775, 10.1111/j.1464-5491.2005.01492.x
Huttly, 2004, Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus, Prenat Diagn, 24, 804, 10.1002/pd.994
American Diabetes Association, 2004, Preconception care of women with diabetes, Diabetes Care, 27, S76, 10.2337/diacare.27.2007.S76
Holing, 1998, Why don’t women with diabetes plan their pregnancies?, Diabetes Care, 21, 889, 10.2337/diacare.21.6.889
Steel, 1990, Can pre-pregnancy care of diabetic women reduce the risk of abnormal babies?, BMJ, 30, 1070, 10.1136/bmj.301.6760.1070
Ray, 2001, Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis, Q J Med, 94, 435, 10.1093/qjmed/94.8.435
McElvy, 2000, A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels, J Matern Fetal Med, 9, 14, 10.1002/(SICI)1520-6661(200001/02)9:1<14::AID-MFM5>3.0.CO;2-K
Diabetes and Pregnancy Group, France, 2003, French multicentric survey of outcome of pregnancy in women with pregestational diabetes, Diabetes Care, 26, 2990, 10.2337/diacare.26.11.2990
Willhoite, 1993, The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program, Diabetes Care, 16, 450, 10.2337/diacare.16.2.450
Miodovnik, 1988, Major malformations in infants of IDDM women. Vasculopathy and early first-trimester poor glycemic control, Diabetes Care, 11, 713, 10.2337/diacare.11.9.713
Dunne, 1999, Pregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy, Q J Med, 92, 451, 10.1093/qjmed/92.8.451
Hadden, 2001, Northern Ireland Diabetes Group and the Ulster Obstetrical Society. Obstetric and diabetic care for pregnancy in diabetic women: 10 years outcome analysis, 1985–1995, Diabetic Med, 18, 546, 10.1046/j.1464-5491.2001.00520.x
Schaefer, 1997, Congenital malformations in offspring of women with hyperglycemia first detected in pregnancy, Am J Obstet Gynecol, 177, 1165, 10.1016/S0002-9378(97)70035-8